nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Contents
|
|
|
2005 |
26 |
2 |
p. v-vii nvt p. |
artikel |
2 |
Epidemiology of Tuberculosis in the United States
|
Schneider, Eileen |
|
2005 |
26 |
2 |
p. 183-195 13 p. |
artikel |
3 |
Forthcoming Issues
|
|
|
2005 |
26 |
2 |
p. viii- 1 p. |
artikel |
4 |
Genetic Susceptibility to Tuberculosis
|
Bellamy, Richard |
|
2005 |
26 |
2 |
p. 233-246 14 p. |
artikel |
5 |
Global Epidemiology of Tuberculosis
|
Maher, Dermot |
|
2005 |
26 |
2 |
p. 167-182 16 p. |
artikel |
6 |
Index
|
|
|
2005 |
26 |
2 |
p. 349-353 5 p. |
artikel |
7 |
Issues in the Management of HIV-Related Tuberculosis
|
Burman, William J. |
|
2005 |
26 |
2 |
p. 283-294 12 p. |
artikel |
8 |
Molecular Epidemiology: A Tool for Understanding Control of Tuberculosis Transmission
|
Daley, Charles L. |
|
2005 |
26 |
2 |
p. 217-231 15 p. |
artikel |
9 |
New Drugs for Tuberculosis: Current Status and Future Prospects
|
O'Brien, Richard J. |
|
2005 |
26 |
2 |
p. 327-340 14 p. |
artikel |
10 |
The Diagnosis of Tuberculosis
|
Brodie, Daniel |
|
2005 |
26 |
2 |
p. 247-271 25 p. |
artikel |
11 |
The DOTS Strategy for Controlling the Global Tuberculosis Epidemic
|
Frieden, Thomas R. |
|
2005 |
26 |
2 |
p. 197-205 9 p. |
artikel |
12 |
The Global Alliance for Tuberculosis Drug Development—Accomplishments and Future Directions
|
Gardner, Charles A. |
|
2005 |
26 |
2 |
p. 341-347 7 p. |
artikel |
13 |
The Origin and Evolution of Mycobacterium tuberculosis
|
Mostowy, Serge |
|
2005 |
26 |
2 |
p. 207-216 10 p. |
artikel |
14 |
Treatment of Active Tuberculosis: Challenges and Prospects
|
Sahbazian, Behzad |
|
2005 |
26 |
2 |
p. 273-282 10 p. |
artikel |
15 |
Treatment of Latent Tuberculosis Infection: Challenges and Prospects
|
Dooley, Kelly E. |
|
2005 |
26 |
2 |
p. 313-326 14 p. |
artikel |
16 |
Tuberculosis
|
Schluger, Neil W. |
|
2005 |
26 |
2 |
p. ix-x nvt p. |
artikel |
17 |
Tuberculosis in Children
|
Feja, Kristina |
|
2005 |
26 |
2 |
p. 295-312 18 p. |
artikel |